Koa Health, a digital mental healthcare provider offering personalized solutions backed by science, today announced it closed an oversubscribed €30 million ($36 million) Series A funding round. The ...
Kurma Partners joined the round which includes and was initially led by Asabys Partners, along with new investors, VI Partners Swiss Innovation and CDTI Innvierte Economía, and existing investors And...
Repsol, through its private equity investment fund, Repsol Corporate Venturing, and the Spanish metallurgical company IMECAL have created a new company, PERSEO Biotechnology. With this operation, Reps...
Fellow Funders, la firma financiera independiente al servicio de empresas e inversores, y Nowture, el primer ecosistema de inversión y desarrollo integral de proyectos de biotecnología y ciencias de...
El compromiso adquirido con las gestoras es que los 10 millones de euros logren multiplicar por cinco la inversión hasta alcanzar los 50 millones de euros. El dinero se desembolsará a medida que los...
Sociedad Regional de Promoción apoya a Nanovex Biotechnologies desde 2015, año en el que le concedió un préstamo participativo con cargo al entonces llamado Fondo de Capital Semilla (actualmente F...
GENESIS Biomed, a consulting company specialized in R + D projects in biomedicine, has recently established its Business Advisory Board, a multidisciplinary panel of experts, KOL in their respective s...
In 2020, AFB started its early-stage investment strategy in Spain by investing in ARTHex Biotech, a preclinical stage life sciences company focused on the development of the next generation antisense ...
The main source of this funding was venture capital, with a total of €140 million. There were 41 operations in total, up 58% from 2019. This data is from the final version of the “Investment in St...
Aura Biosciences, a clinical-stage oncology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced the closing of an oversubsc...
HoMu Health Ventures, la incubadora y Venture Builder para startups del sector biotech, focalizada en salud reproductiva, ha cerrado su primer año de actividad con nueve proyectos en su incubadora. L...
Gross proceeds of the offering, before deducting underwriting discounts and commissions and other offering expenses payable by LAVA, are expected to be $100.5 million. The offering is expected to clos...